Assessing the non-cancer risk for RDX (hexahydro-1,3,5-trinitro-1,3,5-triazine) using physiologically based pharmacokinetic (PBPK) modeling.

Sweeney, Lisa M; Gut, Chester P; Gargas, Michael L; Reddy, Gunda; Williams, Larry R; Johnson, Mark S

Sweeney, Lisa M; Gut, Chester P; Gargas, Michael L; Reddy, Gunda; Williams, Larry R; Johnson, Mark S.

Affiliation

Sweeney LM; Naval Medical Research Unit-Dayton, Wright-Patterson Air Force Base, OH, USA. lisa.sweeney.ctr@wpafb.af.mil

Regul Toxicol Pharmacol ; 62(1): 107-14, 2012 Feb.

Article in En | MEDLINE | ID: mdl-22197625

Subject(s)

Explosive Agents/toxicity; Models, Biological; Risk Assessment/methods; Triazines/toxicity; Animals; Explosive Agents/pharmacokinetics; Humans; Triazines/pharmacokinetics

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Triazines / Risk Assessment / Explosive Agents / Models, Biological Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Language: En Year: 2012 Type: Article

Fulltext

XML

PubMed Links

Search on Google